Results 211 to 220 of about 6,870,828 (229)

Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: Relation to prognosis and angiogenesis

Lung Cancer, 2007
Birgitte Offersen, Jens Overgaard, Per Pfeiffer   +2 more
exaly  

Structure-function relationships in the receptor for urokinase-type plasminogen activator Comparison to other members of the Ly-6 family and snake venom α-neurotoxins

FEBS Letters, 1994
Vincent Ellis, Michael Ploug
exaly  

Urokinase-type plasminogen activator and malignancy

Fibrinolysis, 1993
openaire   +1 more source

Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B

Thrombosis Research, 2009
Xianguo Wu
exaly  

Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Mediate Human Stem Cell Tropism to Malignant Solid Tumors

Stem Cells, 2008
Marianne Metz, Se Hoon Kim, Karen S Aboody   +2 more
exaly  

UROKINASE-TYPE PLASMINOGEN ACTIVATOR TRANSGENIC MOUSE

2013
OBARA MICHINORI, TERAKOSOSHITA KOICHI, KAWASE YOSUKE, MUKOYA TOMOYO, OSHITA HIROKI, HAMAMURA RIKO   +5 more
openaire   +7 more sources

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

Journal of Cell Biology, 1996
exaly  

Cancer treatment with inhibitors of urokinase-type plasminogen activator and plasmin

Expert Opinion on Investigational Drugs, 2000
Deborah Ornstein
exaly  

Fibrinolytic properties of single chain urokinase-type plasminogen activator (Pro-urokinase)

Fibrinolysis, 1990
D C Rijken
exaly  

The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae.

Journal of Cell Biology, 1995
exaly